Real-Time Monitoring of Circulating Tumor DNA and Study of Prognostic Factors in Patients Treated With CAR-T Cells
NANot yet recruitingINTERVENTIONAL
Enrollment
40
Participants
Timeline
Start Date
January 2, 2023
Primary Completion Date
January 2, 2025
Study Completion Date
January 2, 2026
Conditions
Diffuse Large B Cell Lymphoma
Interventions
OTHER
CAR-T cells monitoring
monitoring of circulating DNA by blood sample
Trial Locations (1)
Unknown
Centre Henri Becquerel, Rouen
All Listed Sponsors
lead
Centre Henri Becquerel
OTHER
NCT05675982 - Real-Time Monitoring of Circulating Tumor DNA and Study of Prognostic Factors in Patients Treated With CAR-T Cells | Biotech Hunter | Biotech Hunter